The FDA approves a new diagnostic tool enhancing precision treatment for advanced endometrial carcinoma, improving patient ...
The U.S. Food and Drug Administration (FDA) has approved the Promega OncoMate ® MSI Dx Analysis System as a companion diagnostic designed to identify patients with microsatellite stable (MSS; defined ...